| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.011 | 0.9 |